再鼎医药一季度收入1.065亿美元 同比增加22%

财中社
08 May

5月8日,再鼎医药(09688/ZLAB)发布公告,2025年第一季度的财务业绩显示,总收入为1.065亿美元,同比增加22%;公司重申全年收入指引为5.6亿至5.9亿美元。经营亏损显著改善,第一季度为5630万美元,同比下降20%,调整后的经营亏损减少25%至3710万美元,公司正稳步朝着在2025年第四季度实现盈利的目标迈进。公告中提到,2025年第一季度的产品收入净额为1.057亿美元。其中...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10